HOOKIPA Pharma Inc (NASDAQ:HOOK)
| 0.5811 Delayed Data As of 3:57pm ET |  +0.0051 / +0.89%Today’s Change | 0.41 Today|||52-Week Range 2.05 | -28.26% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $47.4M |
Company Description
HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.
Contact Information
HOOKIPA Pharma, Inc. 350 Fifth Avenue New York New York 10118 |
Employees
Shareholders
| Individual stakeholders | 9.32% |
| Mutual fund holders | 7.50% |
| Other institutional | 43.45% |
Top Executives
| Jörn Aldag | Chief Executive Officer & Director |
| Christine D. Baker | Chief Operating Officer |
| Reinhard Kandera | Chief Financial Officer & Director |
| Klaus Orlinger | Chief Scientific Officer |
| Roman Necina | Chief Technology & Development Officer |
